Body mass index and risk of inflammatory breast disease: a Mendelian randomization study.
Wei C, Wang X, Zeng J, Zhang G.
Nutr Hosp. 2024 Feb 15;41(1):96-111. doi: 10.20960/nh.04746.
PMID:37522462
The role of body mass index at diagnosis in patients with inflammatory breast cancer.
Borremans K, Nguyen HL, De Schepper M, Lerebours F, Vion R, Clatot F, Berghian A, Maetens M, Isnaldi E, Molinelli C, Lambertini M, Grillo F, Zoppoli G, Dirix L, Punie K, Wildiers H, Smeets A, Nevelsteen I, Neven P, Vincent-Salomon A, Larsimont D, Duhem C, Viens P, Bertucci F, Biganzoli E, Vermeulen P, Floris G, Richard F, Desmedt C.
Breast. 2025 Dec;84:104599. doi: 10.1016/j.breast.2025.104599. Epub 2025 Oct 12.
PMID:41109066
Benign Breast Disorders.
Weaver M, Stuckey A.
Obstet Gynecol Clin North Am. 2022 Mar;49(1):57-72. doi: 10.1016/j.ogc.2021.11.003.
PMID:35168773
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update.
Roskoski R Jr.
Pharmacol Res. 2024 Feb;200:107059. doi: 10.1016/j.phrs.2024.107059. Epub 2024 Jan 11.
PMID:38216005
Re-thinking benign inflammation of the lactating breast: Classification, prevention, and management.
Douglas P.
Womens Health (Lond). 2022 Jan-Dec;18:17455057221091349. doi: 10.1177/17455057221091349.
PMID:35441543
Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention.
Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, Friedman ER, Slingerland JM.
CA Cancer J Clin. 2017 Sep;67(5):378-397. doi: 10.3322/caac.21405. Epub 2017 Aug 1.